Literature DB >> 11884546

Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles.

Hsu-Chen Chiu1, Szu-Yung Yao, Chin-Tien Wang.   

Abstract

Incorporation of the human immunodeficiency virus type 1 (HIV-1) Gag-Pol into virions is thought to be mediated by the N-terminal Gag domain via interaction with the Gag precursor. However, one recent study has demonstrated that the murine leukemia virus Pol can be incorporated into virions independently of Gag-Pol expression, implying a possible interaction between the Pol and Gag precursor. To test whether the HIV-1 Pol can be incorporated into virions on removal of the N-terminal Gag domain and to define sequences required for the incorporation of Gag-Pol into virions in more detail, a series of HIV Gag-Pol expression plasmids with various extensive deletions in the region upstream of the reverse transcriptase (RT) domain was constructed, and viral incorporation of the Gag-Pol deletion mutants was examined by cotransfecting 293T cells with a plasmid expressing Pr55(gag). Analysis indicated that deletion of the N-terminal two-thirds of the gag coding region did not significantly affect the incorporation of Gag-Pol into virions. In contrast, Gag-Pol proteins with deletions covering the capsid (CA) major homology regions and the adjacent C-terminal CA regions were impaired with respect to assembly into virions. However, Gag-Pol with sequences deleted upstream of the protease, or of the RT domain but retaining 15 N-terminal gag codons, could still be rescued into virions at a level about 20% of the wild-type level. When assayed in a nonmyristylated Gag-Pol context, all of the Gag-Pol deletion mutants were incorporated into virions at a level comparable to their myristylated counterparts, suggesting that the incorporation of the Gag-Pol deletion mutants into virions is independent of the N-terminal myristylation signal.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884546      PMCID: PMC136043          DOI: 10.1128/jvi.76.7.3221-3231.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences.

Authors:  L E Henderson; M A Bowers; R C Sowder; S A Serabyn; D G Johnson; J W Bess; L O Arthur; D K Bryant; C Fenselau
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Assembly and processing of avian retroviral gag polyproteins containing linked protease dimers.

Authors:  H Burstein; D Bizub; A M Skalka
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

3.  Form, function, and use of retroviral gag proteins.

Authors:  J W Wills; R C Craven
Journal:  AIDS       Date:  1991-06       Impact factor: 4.177

4.  Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly.

Authors:  R Pal; M S Reitz; E Tschachler; R C Gallo; M G Sarngadharan; F D Veronese
Journal:  AIDS Res Hum Retroviruses       Date:  1990-06       Impact factor: 2.205

5.  Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles.

Authors:  A J Smith; N Srinivasakumar; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

6.  Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity.

Authors:  K A Page; N R Landau; D R Littman
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

7.  Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants.

Authors:  C T Wang; E Barklis
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.

Authors:  J Park; C D Morrow
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

9.  Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant.

Authors:  C T Wang; Y Zhang; J McDermott; E Barklis
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production.

Authors:  J Park; C D Morrow
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

View more
  15 in total

1.  Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1.

Authors:  Rabih Halwani; Ahmad Khorchid; Shan Cen; Lawrence Kleiman
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Sequential deletion of the integrase (Gag-Pol) carboxyl terminus reveals distinct phenotypic classes of defective HIV-1.

Authors:  Kevin D Mohammed; Michael B Topper; Mark A Muesing
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

3.  The SIVmac239 Pr55Gag isoform, SIV p43, suppresses proteolytic cleavage of Pr55Gag.

Authors:  Michael G Nicholson; Sheila A Barber; Janice E Clements
Journal:  Virology       Date:  2006-11-07       Impact factor: 3.616

4.  A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release.

Authors:  Chien-Cheng Chiang; Shiu-Mei Wang; Yen-Yu Pan; Kuo-Jung Huang; Chin-Tien Wang
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

5.  The impact of altered polyprotein ratios on the assembly and infectivity of Mason-Pfizer monkey virus.

Authors:  Zdena Kohoutová; Michaela Rumlová; Martin Andreánsky; Michael Sakalian; Eric Hunter; Iva Pichová; Tomás Ruml
Journal:  Virology       Date:  2008-12-04       Impact factor: 3.616

6.  Incorporation of pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-pol.

Authors:  Shan Cen; Meijuan Niu; Jenan Saadatmand; Fei Guo; Yue Huang; Gary J Nabel; Lawrence Kleiman
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particles.

Authors:  Wei-Hao Liao; Kuo-Jung Huang; Yu-Fen Chang; Shiu-Mei Wang; Ying-Tzu Tseng; Chien-Cheng Chiang; Jaang-Jiun Wang; Chin-Tien Wang
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

8.  Targeting human immunodeficiency virus type 1 assembly, maturation and budding.

Authors:  Johanna Wapling; Seema Srivastava; Miranda Shehu-Xhilaga; Gilda Tachedjian
Journal:  Drug Target Insights       Date:  2007-07-20

9.  Placement of leucine zipper motifs at the carboxyl terminus of HIV-1 protease significantly reduces virion production.

Authors:  Yen-Yu Pan; Shiu-Mei Wang; Kuo-Jung Huang; Chien-Cheng Chiang; Chin-Tien Wang
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240

10.  Gag-Pol Transframe Domain p6* Is Essential for HIV-1 Protease-Mediated Virus Maturation.

Authors:  Fu-Hsien Yu; Ting-An Chou; Wei-Hao Liao; Kuo-Jung Huang; Chin-Tien Wang
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.